Immediate Impact
2 from Science/Nature 54 standout
Citing Papers
Cross-priming in cancer immunology and immunotherapy
2025 Standout
From periphery to center stage: 50 years of advancements in innate immunity
2024 Standout
Works of Tehmina Mustafa being referenced
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
2021
Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Tehmina Mustafa | 909 | 590 | 673 | 75 | 1.2k | |
| Jan Heyckendorf | 852 | 333 | 680 | 53 | 1.1k | |
| Irene Latorre | 919 | 573 | 800 | 60 | 1.2k | |
| Tetsuya Takashima | 877 | 465 | 813 | 37 | 1.3k | |
| Heping Xiao | 647 | 330 | 551 | 76 | 1.1k | |
| Róger Calderón | 834 | 291 | 686 | 73 | 1.1k | |
| Domingo Palmero | 822 | 292 | 733 | 61 | 1.2k | |
| Xinhua Weng | 860 | 306 | 817 | 57 | 1.3k | |
| Anne Ma Dyrhol‐Riise | 916 | 389 | 622 | 70 | 1.4k | |
| Fiona McIntosh | 694 | 317 | 639 | 38 | 1.3k | |
| José-María García-García | 825 | 363 | 652 | 76 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...